Connection

Paolo Gisondi to Aged

Back to Details
This is a "connection" page, showing publications Paolo Gisondi has written about Aged.
Paolo Gisondi
Connection Strength
0.113
Aged
  1. Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience. J Allergy Clin Immunol. 2021 Feb; 147(2):558-560.e1.
    View in: PubMed
    Score: 0.016
  2. The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience. Br J Dermatol. 2020 08; 183(2):373-374.
    View in: PubMed
    Score: 0.016
  3. Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment. J Am Acad Dermatol. 2020 Jul; 83(1):285-287.
    View in: PubMed
    Score: 0.016
  4. Image Gallery: Pyoderma gangrenosum of the penis. Br J Dermatol. 2018 01; 178(1):e62.
    View in: PubMed
    Score: 0.013
  5. Public perception of dermatology and dermatologists in Italy: results from a population-based national survey. J Eur Acad Dermatol Venereol. 2017 Dec; 31(12):2119-2123.
    View in: PubMed
    Score: 0.013
  6. The clinical spectrum of COVID-19-associated cutaneous manifestations: An Italian multicenter study of 200 adult patients. J Am Acad Dermatol. 2021 05; 84(5):1356-1363.
    View in: PubMed
    Score: 0.004
  7. Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study. Expert Opin Biol Ther. 2021 02; 21(2):271-277.
    View in: PubMed
    Score: 0.004
  8. Hidradenitis suppurativa and adalimumab in the COVID-19 era. Eur J Dermatol. 2020 Dec 01; 30(6):748-749.
    View in: PubMed
    Score: 0.004
  9. Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy. Am J Clin Dermatol. 2020 10; 21(5):749-751.
    View in: PubMed
    Score: 0.004
  10. Psoriasis is not associated with cognition, brain imaging markers, and risk for dementia: The Rotterdam Study. J Am Acad Dermatol. 2021 09; 85(3):671-680.
    View in: PubMed
    Score: 0.003
  11. Effects of secukinumab on serum adipocytokines: preliminary data. Reumatismo. 2017 Sep 21; 69(3):105-110.
    View in: PubMed
    Score: 0.003
  12. Primary Cutaneous CD4+ Small/Medium Pleomorphic T-Cell Lymphoproliferative Disorder: A Case Series. J Cutan Med Surg. 2017 Nov/Dec; 21(6):502-506.
    View in: PubMed
    Score: 0.003
  13. A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP). Br J Dermatol. 2017 Jul; 177(1):197-205.
    View in: PubMed
    Score: 0.003
  14. Management of long-term therapy with biological drugs in psoriatic patients with latent tuberculosis infection in real life setting. Dermatol Ther. 2017 Sep; 30(5).
    View in: PubMed
    Score: 0.003
  15. Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage study. Ann Rheum Dis. 2017 Sep; 76(9):1591-1597.
    View in: PubMed
    Score: 0.003
  16. Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature. J Eur Acad Dermatol Venereol. 2017 Nov; 31(11):1853-1859.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.